UnitedHealth Group (UNH) Shares Sold by First Republic Investment Management Inc.

First Republic Investment Management Inc. decreased its stake in UnitedHealth Group (NYSE:UNH) by 1.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 359,279 shares of the healthcare conglomerate’s stock after selling 3,470 shares during the period. First Republic Investment Management Inc.’s holdings in UnitedHealth Group were worth $79,207,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. KBC Group NV boosted its stake in UnitedHealth Group by 4.7% during the 3rd quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock worth $63,416,000 after purchasing an additional 14,672 shares during the period. DekaBank Deutsche Girozentrale boosted its stake in UnitedHealth Group by 2.0% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after purchasing an additional 9,810 shares during the period. Bainco International Investors boosted its stake in UnitedHealth Group by 5.4% during the 3rd quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after purchasing an additional 4,202 shares during the period. Toronto Dominion Bank boosted its stake in UnitedHealth Group by 12.6% during the 4th quarter. Toronto Dominion Bank now owns 432,508 shares of the healthcare conglomerate’s stock worth $95,350,000 after purchasing an additional 48,565 shares during the period. Finally, Norinchukin Bank The boosted its stake in UnitedHealth Group by 2.7% during the 3rd quarter. Norinchukin Bank The now owns 180,773 shares of the healthcare conglomerate’s stock worth $35,405,000 after purchasing an additional 4,838 shares during the period. Institutional investors and hedge funds own 86.79% of the company’s stock.

How to Become a New Pot Stock Millionaire

UNH has been the subject of a number of recent research reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a research note on Tuesday, April 3rd. Deutsche Bank increased their price target on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Cantor Fitzgerald restated a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 16th. BMO Capital Markets upped their price objective on shares of UnitedHealth Group from $14.50 to $275.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $244.06.

In related news, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the sale, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction dated Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the completion of the sale, the director now directly owns 76,637 shares in the company, valued at $18,881,824.06. The disclosure for this sale can be found here. Over the last three months, insiders sold 77,015 shares of company stock worth $17,879,199. 0.89% of the stock is owned by corporate insiders.

Shares of UNH opened at $223.96 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $221,662.55, a PE ratio of 22.24, a P/E/G ratio of 1.33 and a beta of 0.77. UnitedHealth Group has a 52-week low of $164.60 and a 52-week high of $250.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s revenue was up 9.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.11 EPS. equities research analysts forecast that UnitedHealth Group will post 12.51 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were issued a $0.75 dividend. The ex-dividend date was Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. UnitedHealth Group’s dividend payout ratio is presently 29.79%.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3340191/unitedhealth-group-unh-shares-sold-by-first-republic-investment-management-inc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Baidu  Downgraded by Zacks Investment Research
Baidu Downgraded by Zacks Investment Research
$177.37 Million in Sales Expected for Omnicell Technologies  This Quarter
$177.37 Million in Sales Expected for Omnicell Technologies This Quarter
Hess  Hits New 1-Year High and Low at $59.56
Hess Hits New 1-Year High and Low at $59.56
Cadence Bancorp  Sets New 52-Week High and Low at $29.40
Cadence Bancorp Sets New 52-Week High and Low at $29.40
Short Interest in Lilis Energy  Increases By 6.9%
Short Interest in Lilis Energy Increases By 6.9%
Globalstar  Short Interest Up 6.9% in April
Globalstar Short Interest Up 6.9% in April


© 2006-2018 Ticker Report. Google+.